These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7982288)

  • 1. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography.
    Zhuo J; Song K; Abdelrahman A; Mendelsohn FA
    Clin Exp Pharmacol Physiol; 1994 Jul; 21(7):557-67. PubMed ID: 7982288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
    Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
    Am J Hypertens; 2000 Sep; 13(9):1005-13. PubMed ID: 10981551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors.
    Song KF; Zhuo JL; Mendelsohn FA
    Br J Pharmacol; 1991 Dec; 104(4):771-2. PubMed ID: 1810594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides.
    Feuillan PP; Millan MA; Aguilera G
    Regul Pept; 1993 Mar; 44(2):159-69. PubMed ID: 8469771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.
    Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE
    Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist.
    Pals DT; Couch SJ
    Clin Exp Hypertens; 1993 Jan; 15(1):1-13. PubMed ID: 8385523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of angiotensin II receptor subtypes in peripheral tissues of spontaneously hypertensive rats by in vitro autoradiography.
    Song K; Kurobe Y; Kanehara H; Wada T; Inada Y; Nishikawa K; Miyazaki M
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S17-9. PubMed ID: 9072342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dietary sodium restriction on angiotensin II receptors in rat adrenals.
    Lehoux JG; Bird IM; Briere N; Martel D; Ducharme L
    Endocrinology; 1997 Dec; 138(12):5238-47. PubMed ID: 9389507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O; Kushida H; Kunihara M
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177.
    Okunishi H; Song K; Oka Y; Kobayashi T; Kawamoto T; Ishihara H; Mori N; Miyazaki M
    Jpn J Pharmacol; 1993 Jul; 62(3):239-44. PubMed ID: 8411773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
    Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
    Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiotensin AT2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation.
    Breault L; Lehoux JG; Gallo-Payet N
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3914-22. PubMed ID: 8923838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
    Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
    Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.